The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease-Reference-Cited by-同舟云学术

The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease

Published:2017-10-26 Issue:1 Volume:9 Page:
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alz Res Therapy

Author:

Ritchie Craig W.,Russ Tom C.,Banerjee Sube,Barber Bob,Boaden Andrew,Fox Nick C.,Holmes Clive,Isaacs Jeremy D.,Leroi Ira,Lovestone Simon,Norton Matt,O’Brien John,Pearson Jim,Perry Richard,Pickett James,Waldman Adam D.,Wong Wai Lup,Rossor Martin N.,Burns Alistair

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1186/s13195-017-0312-4.pdf

Reference18 articles.

1. World Health Organization. Alzheimer’s Disease International: Dementia: a public health priority. Geneva: World Health Organization; 2012.

2. Prince M, Guerchet M, Prina M. Alzheimer’s Disease International: Policy brief for heads of government: the global impact of dementia 2013–2050. London: Alzheimer Disease International; 2013.

3. Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M. Alzheimer’s disease: clinical trials and drug development. Lancet Neurol. 2010;9:702–16.

4. Cummings J, Morstorf T, Lee G. Alzheimer’s drug-development pipeline. Alzheimers Dement. 2016;2:222–32.

5. Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature. 2016;537:50–6.

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alzheimer disease blood biomarkers: considerations for population-level use;Nature Reviews Neurology;2024-06-11

2. Dissonance in the face of Alzheimer's disease breakthroughs: clinician and lay stakeholder acceptance, concerns and willingness to pay for emerging disease-modifying therapies;The British Journal of Psychiatry;2024-04-17

3. Toward the right treatment at the right time: Modeling the trajectory of cognitive decline to identify the earliest age of change in people with Alzheimer's disease;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-01

4. Delivering disease modifying treatments in Alzheimer's disease—An old age psychiatry UK perspective;International Journal of Geriatric Psychiatry;2023-12

5. Life-Course Brain Health as a Determinant of Late-Life Mental Health: American Association for Geriatric Psychiatry Expert Panel Recommendations;The American Journal of Geriatric Psychiatry;2023-12